Key Market Indicators
Canadian antirheumatic medicine sales are set to drop 4.5% by 2026, according to a recent report. In 2021, the market was worth $180 million, down 0.7% from 2017. Germany, Spain, and Canada rounded out the top four in antirheumatic medicine sales in 2021, with Spain taking the lead at $235 million.